Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Amdocs Ltd (NASDAQ: DOX) weakened during the last several trading days. DOX’s current Value Trend Rating is D and the […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for MACOM Technology Solutions Holdi (NASDAQ: MTSI) weakened of late. MTSI’s current Value Trend Rating is D and the prior Rating […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for GSK plc (NYSE: GSK) weakened of late. GSK’s current Value Trend Rating is D and the prior Rating was C. […]
Stock Rating Downgrade In the last week the Value Trend Rating for Five Below Inc (NASDAQ: FIVE) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action On 4/8/24, Five […]
Stock Rating Downgrade During the last several trading days the Value Trend Rating for Escalade Inc (NASDAQ: ESCA) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Escalade Inc […]
Stock Rating Downgrade In the last week the Value Trend Rating for B&G Foods Inc (NYSE: BGS) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action B&G Foods Inc […]
Albany International Corp. (NYSE: AIN) suffers from extremely meaningful negative changes in investment behavior: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, its longer term price […]
Stock Rating Downgrade The Value Trend Rating for Transcat Inc (NASDAQ: TRNS) weakened of late from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for The Chemours Co (NYSE: CC) weakened recently. CC’s current Value Trend Rating is D and the prior Rating was C. […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for OncoGenex Pharmaceuticals Inc (NASDAQ: VRSK) weakened in the last week. VRSK’s current Value Trend Rating is D and the prior […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research